Frankel Stanley
SEC Form 4 insider trading activity
Frankel Stanley has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: May 22, 2026.
On the most recent filing, Frankel Stanley is listed as Director at PRECISION BIOSCIENCES INC. Inside the rolling window, Frankel Stanley reported 2 open-market purchases totaling $26K in DTIL and no open-market sales. The largest disclosed transaction in the window is a purchase of 2,700 DTIL shares on Sep 26, 2025, worth $13K.
Companies traded
Other insiders at DTIL
Insider Buying
$26K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Frankel Stanley made?
Frankel Stanley has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Frankel Stanley trade?
Frankel Stanley has filed SEC Form 4 disclosures for 1 company, including DTIL.
When was Frankel Stanley's most recent SEC Form 4 filing?
Frankel Stanley's most recent SEC Form 4 filing on Tracefour is dated May 22, 2026.
What is Frankel Stanley's total buy and sell value in the current window?
Inside the rolling retention window, Frankel Stanley bought $26K and sold $0 based on SEC Form 4 filings.
What was Frankel Stanley's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 2,700 DTIL shares on 2025-09-26, worth $13K, per SEC Form 4 filings.